Box score
Regentis Biomaterials Ltd.
Reported $6.5M sold in a new Form D filed June 25, 2026 (Herzliya, outside the US).
- Biggest raise
- $6.5M filed Jun 25, 2026
- League
- Bio & Health Biotechnology
- Based in
- Herzliya, outside the US
- Season rank
- #276 of 1,121 in the Bio & Health League; #2411 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-06-25 | New notice | $6.5M | $6.5M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1912966.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Pulsenmore Ltd. rookie provisional | Bio & Health | $7.5M |
| 2 | Vesalius Longevity Labs (SPV) Inc. | Bio & Health | $6.7M |
| 3 | Federated Biologics Inc. rookie | Bio & Health | $6M |
| 4 | EnteroBiotix LTD | Bio & Health | $5.3M |
| 5 | CASI Pharmaceuticals, Inc. | Bio & Health | $5M |
| 6 | CASI Pharmaceuticals, Inc. | Bio & Health | $5M |